MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • All Meetings
    • 2026 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Articles tagged "Non-motor Scales"

  • 2022 International Congress

    Frequency of non-motor symptoms in GBA-PD may differ in carriers of mild vs. severe pathogenic variants

    T. Usnich, N. Brüggemann, M. Olmedillas, N. Schell, I. Csoti, S. Ertan, D. Gruber, S. Zittel, E. Sammler, S. Isaacson, A. Kühn, D. Pedrosa, K. Reetz, A. Sah, M. Kasten, P. Bauer, C. Klein (Lübeck, Germany)

    Objective: Parkinson's disease (PD) patients with pathogenic variants in the GBA (glucocerebrosidase) gene (GBA-PD) were reported to exhibit a younger age at onset, faster progression…
  • 2022 International Congress

    Characterization of nociplastic pains in Parkinson’s disease (PD) with the PD pain classification system (PD-PCS)

    V. Mylius, S. Lloret, N. Fisch, R. Gonzenbach, G. Kägi, J. Möller, F. Brugger, D. de Andrade (Valens, Switzerland)

    Objective: To describe the new category of nociplastic pain (NP). We defined Parkinson's disease (PD)-related pains and allocated them to a mechanistic category by using the…
  • 2022 International Congress

    Social cognition in Parkinson’s disease

    G. Siripurapu, R. Rajan, D. M R, E. A, A. Gupta, V. V Y, M. Singh, R. Bhatia, M. Tripathi, A. Srivastava, M. Srivastava, B. Verma, D. Biswas (NEW DELHI, India)

    Objective: Objective: To assess deficits in social cognition among patients with Parkinson’s Disease (PD) Background: Background: Social cognition is the study of how people make…
  • 2022 International Congress

    Functional Rating Scale 2.0 (FuRST2.0), a patient reported outcome measure for Huntington’s disease: The importance of the patient voice in scale development

    R. Fuller, P. Feigenbaum, N. Lapelle, S. Sathe, C. Fitzer-Attas, M. Guttman, C. Goetz, S. Luo, B. Tilley, P. Dalal, C. Sampaio, G. Stebbins (Princeton, USA)

    Objective: Use focus groups, a Delphi panel, and multiple iterations of cognitive pretesting to develop a patient-reported outcome (PRO) measure of function in Huntington’s disease…
  • 2022 International Congress

    Factors associated with progression of Parkinson’s disease and deterioration in quality of life: Results of J-FIRST, a 1-year observational study

    K. Kashihara, S. Chiu, Y. Tsuboi, N. Hattori, M. Nomoto, H. Watanabe, T. Maeda, H. Saiki, Y. Shimo, T. Yamaguchi (Okayama, Japan)

    Objective: To investigate whether individual non-motor symptoms (NMSs) are associated with overall NMS or quality of life (QOL) in Parkinson's disease (PD). Background: Worsening motor…
  • 2022 International Congress

    Neuropsychological evaluation of cerebellar cognitive function in a series of patients with genetically confirmed CANVAS.

    I. Albajar, J. Equiza, A. Lopez-de-Munain, M. Barandiaran, A. Pujol Onofre, J. Ruiz, M. Maneiro, E. Mondragon, A. Vargas, V. Velez, M. Ruiz Sales, E. Verdura Peralta, P. Iruzubieta (San Sebastian, Spain)

    Objective: We aim to present the cerebellar cognitive affective evaluation and phenotypic description of a series of genetically confirmed CANVAS. Background: Cerebellar ataxia, neuropathy and…
  • 2022 International Congress

    The non-motor features of essential tremor with midline distribution

    A. Rekik, I. Kacem, S. Mrabet, Y. Abida, A. Gharbi, A. Souissi, A. Gargouri, A. Nasri, R. Gouider (Tunis, Tunisia)

    Objective: To investigate the non-motor signs among essential tremor (ET) patients presenting with midline tremor (Mid-ET). Background: Midline essential tremor represents a distinctive group of…
  • 2022 International Congress

    Determinants of symptom severity in Parkinson’s disease: the International Vacation Survey

    J. Janssen Daalen, J. Hubbers, M. Sharifi Bonab, S. Mathur, D. Thijssen, B. Bloem, M. Meinders (Nijmegen, Netherlands)

    Objective: As insight in the drivers of varying symptom severity might help manage symptoms, this study investigates the association between symptom severity and contextual factors…
  • 2022 International Congress

    Impact on non-motor symptoms, cognition, and QoL after 1-year of DBS for Parkinson’s Disease: An interim report from the ADROIT NAPA sub-study

    M. Poetter-Nerger, S. Groppa, O. Adam, A. Schnitzler, M. Navas Garcia, B. Cheeran, L. Himes, M. Frassica, A. Gharabaghi (Hamburg, Germany)

    Objective: To present the impact on cognition, quality of life, and non-motor symptoms after 1-year of DBS for Parkinson’s Disease through the ADROIT post-market study.…
  • 2022 International Congress

    Validation of the English version of the Parkinson Anxiety Scale in the Canadian population: Interim results

    J. Lam, X. Tang, D. Meng, P. Uzelman, A. Yu, S. Appel-Cresswell (Vancouver, Canada)

    Objective: To validate the use of the English version of the PAS in Parkinson’s disease (PD) patients in Canada. Background: The PAS, originally developed to…
  • « Previous Page
  • 1
  • …
  • 27
  • 28
  • 29
  • 30
  • 31
  • …
  • 63
  • Next Page »

Related Sites

International Parkinson and Movement Disorder Society

The Society that manages the annual International Congress »

International Congress

The official website for the International Congress of Parkinson’s and Movement Disorders® »

  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2026 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley